Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
The present invention relates to novel pharmaceutical compositions comprising at least one EGFR kinase inhibitor and at least one additional active compound selected from beta-2 mimetics, steroids, PDE-IV inhibitors, p38 MAP kinase inhibitors, NK1 antagonists and endothelin-antagonists, processes fo...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
16.02.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to novel pharmaceutical compositions comprising at least one EGFR kinase inhibitor and at least one additional active compound selected from beta-2 mimetics, steroids, PDE-IV inhibitors, p38 MAP kinase inhibitors, NK1 antagonists and endothelin-antagonists, processes for preparing the compositions and the use thereof as medicament in the treatment of respiratory or gastrointestinal complaints, as well as inflammatory diseases of the joints, the skin or the eyes. |
---|---|
Bibliography: | Application Number: US20050189643 |